Novel Oral Anticoagulant versus Warfarin in Cancer Patients with Atrial Fibrillation: An 8-Year Population-Based Cohort Study

類似資料

• Safety and Effectiveness of Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study
  著者:: Wang, Chun‐Li, 等
  出版事項: (2019)
• Novel oral anticoagulant vs. warfarin in elderly atrial fibrillation patients with normal, mid‐range, and reduced left ventricular ejection fraction
  著者:: Wu, Victor Chien‐Chia, 等
  出版事項: (2020)
• Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study
  著者:: Wang, Chun‐Li, 等
  出版事項: (2018)
• Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
  著者:: Lee, Hsin‐Fu, 等
  出版事項: (2019)
• Direct oral anticoagulants and the risk of osteoporotic fractures in patients with non-valvular atrial fibrillation
  著者:: Kuo, Liang-Tseng, 等
  出版事項: (2021)